Cardiology

Doç. Dr. Emir Dervış

Doctor and researcher Medipol Bahçelievler Üniversite Hastanesi İstanbul
Atrial FibrillationNon-ST Elevated Myocardial InfarctionMyocardial Infarction
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Atrial Fibrillation 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Non-ST Elevated Myocardial Infarction 2 publications
  • Myocardial Infarction 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medipol.com.tr.

  • İleri kardiyak görüntüleme (Transtorasik ve Transözofageal Ekokardiyografi, MitraClip, TriClip görüntüleme uzmanı)
  • Kalp kapak hastalıkları
  • Konjenital kalp hastalıkları
  • Kardiyomiyopatiler
  • Kardiyo-onkoloji
  • Koruyucu Kardiyoloji

CV

Education and experience

From source

Doç. Dr. Emir Derviş 1988 yılında Üsküdar'da doğmuştur. 2012 yılında Karadeniz Teknik Üniversitesi Tıp Fakültesi'nden mezun olarak tıp doktoru unvanını almıştır. 2012-2017 yılları arasında Kocaeli Üniversitesi Kardiyoloji Anabilim Dalı'nda uzmanlık eğitimini tamamlayarak Kardiyoloji Uzmanı olmuştur.2017-2020 yılları arasında SBÜ Mehmet Akif Ersoy Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi'nde kardiyoloji uzmanı olarak görev yapmıştır. 2020-2022 yılları arasında Başakşehir Çam ve Sakura Şehir Hastanesi'nde çalışmış, 2022 yılından itibaren Bahçelievler Medipol Hastanesi'nde görevine devam etmektedir.2025 yılında Doçent unvanını almıştır. Klinik ve akademik çalışmalarını ileri kardiyak görüntüleme alanında yoğunlaştırmış olup kalp kapak hastalıkları, konjenital kalp hastalıkları, kardiyomiyopatiler ve kardiyo-onkoloji başlıca ilgi alanlarını oluşturmaktadır. Bilimsel kanıta dayalı, hasta odaklı ve güncel uluslararası kılavuzları esas alan bir yaklaşımla sağlık hizmeti sunmayı amaçlamaktadır.

Experience

  • 2020 - 2022BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR HASTANESİmedipol.com.tr
  • 2017 - 2020İSTANBUL MEHMET AKİF ERSOY GÖĞÜS KALP VE DAMAR CERRAHISI EĞITIM VE ARAŞTİRMA HASTANESİmedipol.com.tr

Education

  • 2017Kocaeli Üniversitesi Tıp Fakültesi, Kardiyolojimedipol.com.tr
  • 2012Karadeniz Teknik Üniversitesi, Tıp Fakültesimedipol.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyCardiologymedipol.com.trFrom source
  • InstitutionMedipol Bahçelievler Üniversite Hastanesimedipol.com.trFrom source
  • Area of workAtrial FibrillationExtracted from 3 publications · Model version —From source
  • Publications41 publicationsOpenAlexFrom source
  • Languagesİngilizcemedipol.com.trFrom source
  • Last synchronised4 November 2026 20:19https://medipol.com.tr/doktorlarimiz/docdr-emir-dervismedipol.com.tr

Scientific work

Publications on Atrial Fibrillation

41 publications

  1. Sleep Quality as a Predictor of Coronary Artery Disease Severity in Geriatric Acute Coronary Syndrome

    Medicina, 2026

    DOI 10.3390/medicina62010101 PMID 41597387 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Association of MAPH and CHA₂DS₂-VASc Scores with Left Atrial Thrombus in Atrial Fibrillation Patients Undergoing Ablation: A Comparative Evaluation

    Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2026

    DOI 10.5543/tkda.2026.40525 PMID 41716145 Source: OpenAlex

  3. Reply to the Letter to the Editor: “Albumin as a Pharmacokinetic Confound and the Temporal Validity of the MAPH Score in Atrial Fibrillation”

    Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2026

    DOI 10.5543/tkda.2026.23429 PMID 41928605 Source: OpenAlex

  4. Assessment of The Predictive Value of The Composite Autonomic Symptom Score (COMPASS-31) in Patients with Vasovagal Syncope

    Kocaeli Medical Journal, 2026

    DOI 10.5505/ktd.2026.93342 Source: OpenAlex

  5. Sex differences and gender-related factors in the management and perception of LDL-cholesterol in ASCVD: Real-Life evidence from the EPHESUS registry in cardiology practice

    Atherosclerosis Plus, 2026

    DOI 10.1016/j.athplu.2026.100604 PMID 42740813 Open-access full textSource: OpenAlex

  6. Neutrophil Percentage-to-Albumin Ratio Predicts Contrast-Induced Acute Kidney Injury in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14238367 PMID 41375670 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. The Role of Echocardiographic Right Atrial Strain Parameters in Evaluating Atrial Fibrillation Recurrence in Patients Undergoing Atrial Fibrillation Ablation

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14145155 PMID 40725848 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. The Prognostic Significance of the Pan-Immune-Inflammation Value in Patients with Heart Failure with Reduced Ejection Fraction

    Diagnostics, 2025

    DOI 10.3390/diagnostics15131617 PMID 40647616 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Prognostic impact of Naples prognostic score on long-term mortality in non-ST-elevation myocardial infarction

    Biomarkers in Medicine, 2025

    DOI 10.1080/17520363.2025.2548759 PMID 40817666 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. Do sodium-glucose cotransporter-2 inhibitors provide protection against contrast-induced nephropathy in patients with acute coronary syndrome?

    Journal of Cardiovascular Medicine, 2025

    DOI 10.2459/jcm.0000000000001780 PMID 41118295 2 citations (Europe PMC) Source: OpenAlex

View all 41 publications